Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peng-Chan Lin

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Cancer Management and Research|November 7, 2019
Comprehensive assessment of <i>HER2</i> alteration in a colorectal cancer cohort: from next-generation sequencing to clinical significanceYu-Min Yeh, Chun-Hui Lee, Shang-Hung Chen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 14, 2023
HER2 amplification in colorectal cancer with brain metastasis: A propensity score matching studyPo-Chuan Chen, Yu-Min Yeh, Chun-Ting Chu, et al.
Experimental & Molecular Medicine|June 10, 2018
The EGF/hnRNP Q1 axis is involved in tumorigenesis via the regulation of cell cycle-related genesYu-Chu Wang, Kung-Chao Chang, Bo-Wen Lin, et al.
Oncotarget|April 20, 2017
Serrated adenocarcinoma morphology in colorectal mucinous adenocarcinoma is associated with improved patient survivalChung-Ta Lee, Yu-Chuan Huang, Liang-Yi Hung, et al.
International Journal of Molecular Sciences|November 11, 2022
PD-L1 Expression in High-Risk Early-Stage Colorectal Cancer-Its Clinical and Biological Significance in Immune MicroenvironmentBing-Syuan Chung, I-Chuang Liao, Peng-Chan Lin, et al.
Molecular Oncology|August 3, 2020
Downregulation of STK4 promotes colon cancer invasion/migration through blocking β-catenin degradationCheng-Han Lin, Tai-I Hsu, Pei-Yu Chiou, et al.
Molecular Carcinogenesis|April 4, 2023
Dual role of sprouty2 as an inhibitor of RAS/ERK-driven proliferation and a promoter of cancer invasion in KRAS wild-type colorectal cancerChung-Ta Lee, Chien-An Chu, Yu-Ming Wang, et al.
Theranostics|March 23, 2021
Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathySzu-Jung Chen, Li-Hsien Chen, Yu-Min Yeh, et al.
British Journal of Cancer|August 23, 2022
CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancerChi-Che Hsieh, Sen-Huei Hsu, Chih-Yu Lin, et al.
Cancer Immunology, Immunotherapy : CII|August 12, 2025
Cathepsin S regulates antitumor immunity through autophagic degradation of PD-L1 in colorectal cancer cellsSina Taheri Baghmisheh, Chung-Hsing Chen, Yu-Min Yeh, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Cancer Management and Research|November 7, 2019
Comprehensive assessment of <i>HER2</i> alteration in a colorectal cancer cohort: from next-generation sequencing to clinical significanceYu-Min Yeh, Chun-Hui Lee, Shang-Hung Chen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 14, 2023
HER2 amplification in colorectal cancer with brain metastasis: A propensity score matching studyPo-Chuan Chen, Yu-Min Yeh, Chun-Ting Chu, et al.
Experimental & Molecular Medicine|June 10, 2018
The EGF/hnRNP Q1 axis is involved in tumorigenesis via the regulation of cell cycle-related genesYu-Chu Wang, Kung-Chao Chang, Bo-Wen Lin, et al.
Oncotarget|April 20, 2017
Serrated adenocarcinoma morphology in colorectal mucinous adenocarcinoma is associated with improved patient survivalChung-Ta Lee, Yu-Chuan Huang, Liang-Yi Hung, et al.
International Journal of Molecular Sciences|November 11, 2022
PD-L1 Expression in High-Risk Early-Stage Colorectal Cancer-Its Clinical and Biological Significance in Immune MicroenvironmentBing-Syuan Chung, I-Chuang Liao, Peng-Chan Lin, et al.
Molecular Oncology|August 3, 2020
Downregulation of STK4 promotes colon cancer invasion/migration through blocking β-catenin degradationCheng-Han Lin, Tai-I Hsu, Pei-Yu Chiou, et al.
Molecular Carcinogenesis|April 4, 2023
Dual role of sprouty2 as an inhibitor of RAS/ERK-driven proliferation and a promoter of cancer invasion in KRAS wild-type colorectal cancerChung-Ta Lee, Chien-An Chu, Yu-Ming Wang, et al.
Theranostics|March 23, 2021
Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathySzu-Jung Chen, Li-Hsien Chen, Yu-Min Yeh, et al.
British Journal of Cancer|August 23, 2022
CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancerChi-Che Hsieh, Sen-Huei Hsu, Chih-Yu Lin, et al.
Cancer Immunology, Immunotherapy : CII|August 12, 2025
Cathepsin S regulates antitumor immunity through autophagic degradation of PD-L1 in colorectal cancer cellsSina Taheri Baghmisheh, Chung-Hsing Chen, Yu-Min Yeh, et al.
Pageof 9